Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 11-12/2015

01.06.2015 | original article

Patient’s and physician’s behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by “Prostate and Expectations of Treatment: Epidemiology Research” (PETER) study group

verfasst von: MD Peter Weibl, Peter Laurinc, Roman Tomaškin, Tobias Klatte, Shahrokh Shariat F, Miroslav Helbich, Danica Fačkovcova, Peter Bujdák

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2015

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Objectives

The aim of the survey was to assess physician’s behavior and the global knowledge about patient’s preferences and their psychological burden linked to lower urinary tract symptoms (LUTS) in an outpatient setting in Slovakia.

Methods

The study included 36 outpatient urological clinics. Overall, 1132 newly diagnosed LUTS patients were screened within 1 month. A total of 454 questionnaires were obtained from 459 LUTS patients with risk of progression (RP). Inclusion criteria were: age > 50 years, IPSS > 8, prostate volume ≥ 30 cm3, and PSA ≥ 1.5 to ≤ 10 ng/ml.

Results

The digital rectal examination, PSA testing, and urinalysis were used in all the centers as first visit examinations. The least frequently performed diagnostic procedure was uroflowmetry (74 %). The physician’s preferred therapy for patients with RP was standard combined treatment in (52.6 %); followed by α-blocker alone (45 %) and monotherapy with 5-α-reductase inhibitors (5-ARI) only in 3 % of all asked urologists. Patient’s mean age was 63.3 years (SD ±  7.4); baseline PSA value 2.2 ng/ml (SD + 3.2); prostate volume was 38.0 ml (SD ±  16.7 ml); Qmax was 11.5 ml/s (SD ±  4.6); and IPSS score 12.5 (SD ±  6.3). The most bothersome symptoms were nocturia (prevalence of ≥ 75 %), weak urinary stream (61 %), and retarded voiding (43 %). Patient’s expectations of treatment were rapid improvement of symptoms (36.0 %), stabilization of symptoms (35.5 %), and reduction of potential risk of surgical intervention (25.8 %).

Conclusions

Our research reflects the physician’s behavior, patient’s self-perception of the disease and therapeutic priorities in the current outpatient practice in Slovakia.
Literatur
1.
Zurück zum Zitat Teillac P. Benign prostatic hyperplasia: patients perception of medical treatment and their expectations: results of French survey involving patients treated with finasteride. Therapie. 2002;57:473–83. PubMed Teillac P. Benign prostatic hyperplasia: patients perception of medical treatment and their expectations: results of French survey involving patients treated with finasteride. Therapie. 2002;57:473–83. PubMed
2.
Zurück zum Zitat Hong SJ1, Rayford W, Valiquette L, et al. The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management. BJU Int. 2005;95(1):15–9. PubMedCrossRef Hong SJ1, Rayford W, Valiquette L, et al. The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management. BJU Int. 2005;95(1):15–9. PubMedCrossRef
3.
Zurück zum Zitat Kaplan S, Naslund M. Public, patient, and professional attitudes towards the diagnosis and treatment of enlarged prostate: a landmark national US survey. Int J Clin Pract. 2006;60(10):1157–65. PubMedCrossRef Kaplan S, Naslund M. Public, patient, and professional attitudes towards the diagnosis and treatment of enlarged prostate: a landmark national US survey. Int J Clin Pract. 2006;60(10):1157–65. PubMedCrossRef
4.
Zurück zum Zitat Emberton M, Marberger M, Rosette Jdl. Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: the prostate research on behavior and education (PROBE) survey. Int J Clin Pract. 2007;62(1):18–26. PubMedCrossRef Emberton M, Marberger M, Rosette Jdl. Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: the prostate research on behavior and education (PROBE) survey. Int J Clin Pract. 2007;62(1):18–26. PubMedCrossRef
5.
Zurück zum Zitat Emberton M. Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction. Int J Clin Pract. 2010;64(10):1425–35. PubMedCrossRef Emberton M. Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction. Int J Clin Pract. 2010;64(10):1425–35. PubMedCrossRef
6.
Zurück zum Zitat Parsons JK, Wilt TJ, Wang PY, et al. Osteoporotic Fractures in Men Research Group. Progression of lower urinary tract symptoms in older men: a community based study. J Urol. 2010;183(5):1915–20. PubMedCentralPubMedCrossRef Parsons JK, Wilt TJ, Wang PY, et al. Osteoporotic Fractures in Men Research Group. Progression of lower urinary tract symptoms in older men: a community based study. J Urol. 2010;183(5):1915–20. PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Maserejian NN, Chen S, Chiu GR, et al. Treatment status and progression or regression of lower urinary tract symptoms in a general adult population sample. J Urol. 2014;191(1):107–13. PubMedCentralPubMedCrossRef Maserejian NN, Chen S, Chiu GR, et al. Treatment status and progression or regression of lower urinary tract symptoms in a general adult population sample. J Urol. 2014;191(1):107–13. PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803. PubMedCrossRef McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803. PubMedCrossRef
9.
Zurück zum Zitat Madersbacher S1, Alivizatos G, Nordling J, et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004;46(5):547–54. PubMedCrossRef Madersbacher S1, Alivizatos G, Nordling J, et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004;46(5):547–54. PubMedCrossRef
Metadaten
Titel
Patient’s and physician’s behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by “Prostate and Expectations of Treatment: Epidemiology Research” (PETER) study group
verfasst von
MD Peter Weibl
Peter Laurinc
Roman Tomaškin
Tobias Klatte
Shahrokh Shariat F
Miroslav Helbich
Danica Fačkovcova
Peter Bujdák
Publikationsdatum
01.06.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 11-12/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0751-5

Weitere Artikel der Ausgabe 11-12/2015

Wiener klinische Wochenschrift 11-12/2015 Zur Ausgabe